Regulus Therapeutics Inc (NASDAQ:RGLS)

0.2325
Delayed Data
As of Jun 24
 -0.0276 / -10.61%
Today’s Change
0.16
Today|||52-Week Range
1.05
-26.19%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close0.26
Today’s open0.27
Day’s range0.23 - 0.27
Volume66,382
Average volume (3 months)1,832,685
Market cap$35.1M
Data as of 4:00pm ET, 06/24/2022

Growth & Valuation

Earnings growth (last year)+27.84%
Earnings growth (this year)+39.30%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book0.64

Competitors

----
ERYPErytech Pharma SA+0.01+0.88%
TNXPTonix Pharmaceutical...-0.11-5.53%
ABIOARCA Biopharma Inc-0.04-1.58%
Data as of 4:24pm ET, 06/24/2022

Financials

Next reporting dateAugust 11, 2022
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$27.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
San Diego, California

Forecasts